Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone ...

The first oral pill for obstructive sleep apnea could be around the corner after company Apnimed reported positive results ...

Of the four major GLP-1 drugs on the market, only Zepbound and Mounjaro (known generically as tirzepatide) are FDA-approved to treat sleep apnea in those with a body mass index (BMI) of 30 or higher.

In today’s Health Alert, obstructive sleep apnea may soon be treated with a simple, once-a-day pill. This first-in-class oral ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...

Apnimed's experimental drug reduced breathing interruptions by nearly 46.8% in clinical trials, offering a potential ...

Additionally, Zepbound is FDA-approved to treat adults with moderate-to-severe obstructive sleep apnea and obesity. Zepbound should be used with a reduced-calorie diet and increased physical activity.